A new two-dimensional (2D) organic small molecule, DCA3T(T-BDT), was designed and synthesized for solution-processed organic solar cells (OSCs). DCA3T(T-BDT) exhibited a deep HOMO energy level (−5.37 eV) and good thermal stability. The morphologies of the DCA3T(T-BDT):[6,6]-phenyl-C61-butyric acid methyl ester (PC61BM) blends were investigated by atomic force microscopy and the crystallinity was explored by X-ray diffraction (XRD) and 2D grazing incidence wide-angle X-ray scattering (GIWAXS), respectively. The morphologies of the blends were strongly influenced by the blend ratio of DCA3T(T-BDT):PC61BM and annealing temperature. The effect of thermal annealing on the photovoltaic performance of DCA3T(T-BDT)-based small molecule organic solar cells (SMOSCs) was studied in detail. When DCA3T(T-BDT) was used as a donor with PC61BM as an acceptor, high efficiency SMOSCs with a power conversion efficiency of 7.93%, a high Voc of 0.95 V, Jsc of 11.86 mA cm−2 and FF of 0.70 were obtained by a thermal annealing process at only 60 °C, which offers obvious advantages for large scale production compared with solvent additive or interfacial modification treatment.
No takes yet. Share an insight, caveat, or question.
Du et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: